Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (181-190 of 477) with videos related to

Pageof 48
Sort By:
RMD Open|April 19, 2019
Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT studyPaul Emery, Gerd R Burmester, Vivian P Bykerk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 4, 2021
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung DiseaseDavid Roofeh, Celia J F Lin, Jonathan Goldin, et al.
Arthritis and Rheumatism|June 10, 2004
Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosisPhilip J Clements, Jonathan G Goldin, Eric C Kleerup, et al.
Arthritis and Rheumatism|April 3, 2008
Prepared patients: internet information seeking by new rheumatology patientsM Cameron Hay, R Jean Cadigan, Dinesh Khanna, et al.
Annals of the Rheumatic Diseases|July 16, 2013
Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD studyElisabeth Lie, Thasia G Woodworth, Robin Christensen, et al.
Arthritis and Rheumatism|August 1, 2009
Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trialsSogol Amjadi, Paul Maranian, Daniel E Furst, et al.
Seminars in Arthritis and Rheumatism|June 19, 2017
High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic SclerosisHanan Sayed M Abozaid, Hala M K Imam, Marwa Mahmoud Abdelaziz, et al.
The Journal of Rheumatology|September 12, 2008
Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA databaseVeena K Ranganath, Harold E Paulus, Alina Onofrei, et al.
Rheumatology International|October 21, 2018
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Clinical Rheumatology|January 1, 2022
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)Ruediger B Mueller, Hendrik Schulze-Koops, Daniel E Furst, et al.
Pageof 48

Showing results (181-190 of 477) with videos related to

Sort By:
Pageof 48
RMD Open|April 19, 2019
Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT studyPaul Emery, Gerd R Burmester, Vivian P Bykerk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 4, 2021
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung DiseaseDavid Roofeh, Celia J F Lin, Jonathan Goldin, et al.
Arthritis and Rheumatism|June 10, 2004
Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosisPhilip J Clements, Jonathan G Goldin, Eric C Kleerup, et al.
Arthritis and Rheumatism|April 3, 2008
Prepared patients: internet information seeking by new rheumatology patientsM Cameron Hay, R Jean Cadigan, Dinesh Khanna, et al.
Annals of the Rheumatic Diseases|July 16, 2013
Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD studyElisabeth Lie, Thasia G Woodworth, Robin Christensen, et al.
Arthritis and Rheumatism|August 1, 2009
Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trialsSogol Amjadi, Paul Maranian, Daniel E Furst, et al.
Seminars in Arthritis and Rheumatism|June 19, 2017
High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic SclerosisHanan Sayed M Abozaid, Hala M K Imam, Marwa Mahmoud Abdelaziz, et al.
The Journal of Rheumatology|September 12, 2008
Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA databaseVeena K Ranganath, Harold E Paulus, Alina Onofrei, et al.
Rheumatology International|October 21, 2018
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Clinical Rheumatology|January 1, 2022
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)Ruediger B Mueller, Hendrik Schulze-Koops, Daniel E Furst, et al.
Pageof 48